Drug combination improves progression-free survival in melanoma patients
Patients with advanced melanoma skin cancer survive for longer without their disease progressing if they have been treated with a combination of two drugs, nivolumab and ipilimumab, than with either of these drugs alone. ...
Sep 28, 2015
0
20